medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2007, Number 02

<< Back Next >>

Ginecol Obstet Mex 2007; 75 (02)

Perception of gyneco-obstetric physicians about hormone replacement therapy

Carranza LS, Fragoso DJ
Full text How to cite this article

Language: Spanish
References: 9
Page: 86-94
PDF size: 160.64 Kb.


Key words:

hormone therapy, interview, opinion, WHI trial, climacterium.

ABSTRACT

Objective: To identify which is the medical perception of the gynecology-obstetric physicians (Ob-Gyn’s) according to hormone therapy (HT) after WHI trial.
Material and methods: 104 Ob-Gyn were interrogated, and divided into 5 groups according to their position in the hospital. Descriptive statistics was used and the comparisons were done with Student’s t test.
Results: 31.7% of the interviewed were in the fifth decade of life and 71% were male. 93.6% referred that HT might not be used in postmenopausal women older 50 years age. Most of them considered that HT decreases osteoporosis and depression. 90.4% considered that HT must be used premature menopause. 91.3% prescribed progestagens in patients with uterus. Oral route was preferred by 50% and the transdermic in 30.8%. 80.8% referred that combined HT did not increase the possibility of endometrial cancer but it did for breast cancer (71.2%). In the same way they considered that improved vaginal lubrication (95.2%), mood (87.5%), hot-flushes (92.3%) and menstrual disturbances (80.8%). 95.2% considered that HT improves quality of life. 62.5% referred that WHI trial modified the way they prescribe HT. 80.8% considered that low dose HT is as good as conventional dose HT.
Conclusions: This interview permitted to know the opinion in relation to HT, without difference between the interviewed and world tendency.


REFERENCES

  1. Isaacs AJ, Briton AR, McPherson K. Utilisation of hormone replacement therapy by women doctors. BMJ 1995;311:1399-1401.

  2. Norman SG, Studd JW. A survey of views on hormone replacement therapy. Br J Obstet Gynaecol 1994;101:879-87.

  3. Elinson L, Cohen M, Elmslie T. Hormone replacement therapy: a survey of Ontario physicians prescribing practices. CMAJ 1999;161:695-8.

  4. Hemminki E, Topo P, Malin M, Kangas I. Physicians’ views on hormone therapy around and after menopause. Maturitas 1993;16:163-73.

  5. Shafi S, Samad Z, Syed S, Sharif A, et al. Hormone replacement therapy menopause with a better future: a survey of views on hormone replacement therapy. J Pak Med Assoc 2001;51:450-3.

  6. Huston S, Sleath B, Rubin R. Physician gender and hormone replacement therapy discussion. J Womens Health Gend Based Med 2001;10:279-87.

  7. Baron J, Holzman GB, Schulkin J. Attitudes of obstetricians and gynecologists toward hormone replacement therapy. Med Decis Making 1998;18:406-11.

  8. Blumel JE, Castelo-Branco C, Chedraui PA, Binfa L, et al. Patients’ and clinicians’ attitudes after the Women’s Health Initiative study. Menopause 2004;11:57-61.

  9. Rozenberg S, Vasquez JB. Estrogen replacement therapy in patients with endometrial cancer: prescription attitude of Belgian gynecologists. Maturitas 2000;35:125-8.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2007;75